Form 4: Lemaitre Vascular Director Acquires Shares Through Dividend Equivalent Rights Vesting

Director John James O'Connor acquired shares of Lemaitre Vascular Inc. through the vesting of dividend equivalent rights associated with restricted stock units and performance stock units.

Summary

• John James O'Connor, a director at Lemaitre Vascular Inc., acquired a total of 12 shares of common stock.
• These shares were obtained through the vesting of dividend equivalent rights.
• The dividend equivalent rights were associated with restricted stock unit awards granted on December 11, 2021, and December 12, 2022, as well as a performance stock unit award granted on December 12, 2022.
• The transactions occurred on December 11 and 12, 2024.
• The price per share for these transactions was $0 as they were acquired through the vesting of rights.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation. It is neither particularly positive nor negative, but indicates that the director is receiving compensation as expected.

Positives

• The vesting of dividend equivalent rights indicates that performance and time-based vesting conditions have been met.
• The director's increased shareholding aligns their interests with those of other shareholders.

Industry Context

This is a routine filing related to insider transactions and is common for publicly traded companies. It reflects the standard practice of equity-based compensation for directors and executives.

Comparison to Industry Standards

• The vesting of restricted stock units and performance stock units is a common practice for executive compensation in publicly traded companies.
• Many companies in the medical device industry, such as Medtronic and Boston Scientific, use similar equity-based compensation plans.
• The use of dividend equivalent rights is also a standard practice to ensure that holders of unvested equity receive the economic equivalent of dividends paid on common stock.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with theirs.
• The transaction has no material impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Lemaitre Vascular, Director Shareholding, Dividend Equivalent Rights, Stock Vesting, Form 4, Insider Trading, LMAT